Shopping Cart
- Remove All
- Your shopping cart is currently empty
BrBzGCp2 (p BrBzGSH(Cp)2) is an inhibitor of glyoxalase 1 (GLO1) with antitumor and neuroprotective activity. It can alleviate anxiety and be used in neurodegenerative disease research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $48 | In Stock |
Description | BrBzGCp2 (p BrBzGSH(Cp)2) is an inhibitor of glyoxalase 1 (GLO1) with antitumor and neuroprotective activity. It can alleviate anxiety and be used in neurodegenerative disease research. |
Targets&IC50 | Glyoxalase I:4.23 μM (GC50) |
In vitro | BrBzGCp2 is an inhibitor of glyoxalase 1 (GLO1) with a GC50 of 4.23 μM in HL-60 cells. [1] |
In vivo | BrBzGCp2 demonstrated an increase in dwell time in the central region of mice in open field (OF) experiments, while not significantly altering the distance traveled. GLO1 inhibition attenuated anxiety-like behavior by increasing methylglyoxal (MG) concentration. [2] Pretreatment with BrBzGCp2 shortens seizure duration. [3] BrBzGCp2 injections reduced anxiety levels in mice, and less anxiety and fear led to a greater willingness to explore unknown regions, suggesting that inhibition of GLO1 activity has a positive effect on anxiety relief. Treatment with BrBzGCp2 also restored the inhibitory effect of valproic acid (VPA) on GABAA receptor activation. [4] |
Alias | S-p-Bromobenzylglutathione cyclopentyl diester, pBrBzGSH(Cp)2, p BrBzGSH(Cp)2, BBGD, BBGC |
Molecular Weight | 612.58 |
Formula | C27H38BrN3O6S |
Cas No. | 166038-00-2 |
Smiles | [C@H](CSCC1=CC=C(Br)C=C1)(C(NCC(OC2CCCC2)=O)=O)NC(CC[C@@H](C(OC3CCCC3)=O)N)=O |
Relative Density. | 1.31g/cm3 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 200 mg/mL (326.49 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.